Viking Therapeutics Trend 2026

Viking Therapeutics is a clinical-stage biopharmaceutical firm pioneering innovative therapies for metabolic and endocrine disorders. Its leading candidates target conditions like non-alcoholic steatohepatitis (NASH) and obesity, with promising oral and injectable options. Patients with chronic liver disease, type 2 diabetes, and weight management needs may benefit from these potentially safer, more effective treatments currently in advanced trials.